Tag: cancer diagnostics industry

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Cancer Diagnostics Global Market Report 2024 Market from 2024 to 2033?

The cancer diagnostics market is expected to grow rapidly, from $21.38 billion in 2023 to $23.84 billion in 2024, with a CAGR of 11.5%. Factors driving this growth include rising cancer incidence, cancer screening programs, advances in personalized medicine, and greater public awareness.

The cancer diagnostics market is forecast to see rapid growth, reaching $37.09 billion by 2028, growing at a CAGR of 11.7%. Growth is attributed to expanding markets, regulatory support, and advances in AI and early detection. Trends include liquid biopsies, multi-omics, and point-of-care testing.

Claim Your Free Sample of the Global Cancer Diagnostics Global Market Report 2024 Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

What Key Factors Are Fueling the Growth of the Cancer Diagnostics Global Market Report 2024 Market?

The cancer diagnostics market is growing due to the increasing prevalence of various types of cancer. With cancer being the second-leading cause of death globally, the rising number of new cancer cases is driving the demand for diagnostic services. The National Cancer Institute (NCI) estimates that new cancer cases will reach 23.6 million annually by 2030, contributing to the market’s expansion.

What Are the Major Segments of the Cancer Diagnostics Global Market Report 2024 Market?

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

What New Trends Are Transforming the Cancer Diagnostics Global Market Report 2024 Market?

AI-based cancer detection systems are revolutionizing cancer diagnostics by improving the accuracy of early detection and reducing false positives. For example, a collaboration between the Naval Medical Center San Diego and Google AI developed an AI solution that increased metastatic breast cancer detection accuracy to 99%.

Order Now for Fast Delivery of Your Cancer Diagnostics Global Market Report 2024 Market Report!

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Which Regions Are Driving Growth in the Cancer Diagnostics Global Market Report 2024 Market?

North America was the largest region in the cancer diagnostics market in 2023. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The Cancer Diagnostics Global Market Report 2024 Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the cancer diagnostics global market report 2024 market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Cancer Diagnostics Global Market Report 2024 Market Include

1. Cancer Diagnostics Global Market Report 2024 Market Executive Summary

2. Cancer Diagnostics Global Market Report 2024 Market Segments

3. Cancer Diagnostics Global Market Report 2024 Market Size And Template Market Growth Rate

4. Key Cancer Diagnostics Global Market Report 2024 Market Trends

5. Major Cancer Diagnostics Global Market Report 2024 Market Drivers

……

25. Key Mergers And Acquisitions In The Cancer Diagnostics Global Market Report 2024 Market

26. Top Cancer Diagnostics Global Market Report 2024 Companies

27. Cancer Diagnostics Global Market Report 2024 Market Opportunities And Strategies

28. Cancer Diagnostics Global Market Report 2024 Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Meat Processing Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/meat-processing-equipment-global-market-report

Cancer Biologics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Cancer Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The cancer diagnostics market has witnessed a rapid surge in recent years, reflecting the critical role it plays in identifying and treating various types of cancers. With a market size projected to reach $23.84 billion in 2024 at a compound annual growth rate (CAGR) of 11.5%, the industry is on an upward trajectory. The growth in the historic period can be attributed to increasing cancer incidence, cancer screening programs, personalized medicine, and heightened public awareness.

Current Landscape and Future Projections
The momentum in the cancer diagnostics market shows no signs of slowing down. Projections indicate a robust growth from $21.38 billion in 2023 to $37.09 billion in 2028, boasting a CAGR of 11.7%. This anticipated surge is fueled by factors such as the growth of emerging markets, regulatory support, the integration of artificial intelligence (AI) and machine learning, and a heightened emphasis on early detection and intervention. Notable trends in the forecast period include the rise of liquid biopsies, multi-omics approaches, point-of-care testing, and increased focus on screening and early intervention campaigns.

Rising Cancer Prevalence Rate In Cancer Diagnostics Market
The surge in the prevalence of various types of cancers is a significant driver for the cancer diagnostics market. The increasing incidence of cancers prompts more individuals to seek diagnosis and treatment. According to the World Health Organization, cancer ranks as the second-leading cause of death globally. The National Cancer Institute projects the annual number of new cancer cases to reach 23.6 million by 2030. Key players in this dynamic market include Abbott Laboratories, Becton Dickinson and Company, GE Healthcare Ltd., Siemens Healthcare GmbH, and Thermo Fisher Scientific.

View More On The Cancer Diagnostics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Innovations In Artificial Intelligence (AI) For Cancer Diagnostics Devices Market
A noteworthy trend in the cancer diagnostics market is the integration of AI-based cancer detection systems. AI enhances the accuracy of image detection in various diagnostic processes, such as breast and lung cancer diagnostics, by detecting cancers in their early stages. This technology is instrumental in reducing false positives in lung cancer screening, thereby improving detection accuracy. For example, researchers at the Naval Medical Center San Diego and Google’s AI research division developed algorithms for autonomous evaluation of lymph node biopsies, achieving a remarkable 99% accuracy in metastatic breast cancer detection.

Market Segmentation
Understanding the diverse facets of cancer diagnostics, the market is segmented based on products, methods, applications, and end-users.

1. By Products:
   • Companion Diagnostics
   • Molecular Diagnostics
2. By Method:
   • Biopsy
   • Endoscopy
   • Tumor Biomarker Tests
   • Imaging
3. By Application:
   • Cervical Cancer
   • Breast Cancer
   • Liver Cancer
   • Blood Cancer
   • Kidney Cancer
   • Colorectal Cancer
   • Pancreatic Cancer
   • Ovarian Cancer
   • Melanoma
   • Other Applications
4. By End-User:
   • Cancer Research Institutes
   • Diagnostic Laboratories
   • Hospitals
   • Other End Users

Regional Dominance
As of 2023, North America stands out as the largest region in the global cancer diagnostics market, reflecting the region’s prominence in steering market dynamics.

Conclusion
The rapid growth of the cancer diagnostics market is marked by increasing cancer prevalence rates, technological advancements in AI, and a meticulous focus on early detection and intervention. As the market evolves, companies must continue to embrace innovation, leveraging AI, and staying attuned to emerging trends to address the pressing global challenge of cancer. The journey ahead holds not only financial opportunities but also the promise of improving diagnostic accuracy and ultimately enhancing patient outcomes in the fight against cancer.

Request A Sample Of The Global Cancer Diagnostics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=2570&type=smp

About Company:  TBRC
As a premier market research firm, we specialize in delivering comprehensive insights into customer behavior, market trends, product landscapes, and competitor analysis. Our expertise lies in extracting actionable intelligence through methods such as secondary research, expert interviews, proprietary data, and our extensive in-house knowledge base. With a dedicated team of over 350 experts spanning 28 countries, we curate a repository of 1.5 million datasets across 27 diverse industries, including services, manufacturing, healthcare, financial services, and technology. Our tailored intelligence services empower strategic decision-making, guiding you in market selection, customer targeting, and outmaneuvering competitors.